AMUNIX PHARMACEUTICALS, INC.

Profile

Company Names

AMUNIX PHARMACEUTICALS, INC.

Addresses

2 TOWER PL, #1100, SOUTH SAN FRANCISCO, CA 94080-1826

500 ELLIS ST, MOUNTAIN VIEW, CA 94043

Phone Numbers

650-428-1800

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$200,590,382.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-02-26 
$116,999,980.00 
$116,999,980.00 
$0.00 
Equity 
3
2021-01-07 
$0.00 
$743,277.00 
$743,277.00 
 
2
2020-06-17 
$0.00 
$2,579,360.00 
$2,579,360.00 
 
1
2020-02-28 
$83,590,402.00 
$83,590,402.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
BRUSH 
DIRECTOR
AMUNIX PHARMACEUTICALS, INC.
RICHARD 
 
HEYMAN 
DIRECTOR
METACRINE, INC.   |  YUMANITY HOLDINGS, LLC   |  VIVIDION THERAPEUTICS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  ORIC PHARMACEUTICALS, INC.   |  ENLIVEN THERAPEUTICS, INC.   |  PELAGE PHARMACEUTICALS, INC.
DAVID 
 
HIRSCH 
DIRECTOR
NCRX OPTICAL SOLUTIONS INC   |  PRECISION THERAPEUTICS INC   |  TURIYA MEDIA, INC.   |  CIVITAS THERAPEUTICS, INC.   |  COLLEGIUM PHARMACEUTICAL INC   |  SONGZA, INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  METAMORPHIC VENTURES II, L.P.   |  METAMORPHIC VENTURES II-A, L.P.   |  VOYAT INC.   |  LAUNCHKEY, INC.   |  ONEX YORK CO-INVEST LP   |  COLLEGIUM PHARMACEUTICAL, INC   |  MOVE LOOT, INC.   |  METAMORPHIC VENTURES FD, LLC   |  VELICEPT THERAPEUTICS, INC.   |  GROOP INTERNET PLATFORM INC.   |  ZAVANTE THERAPEUTICS, INC.   |  TRICIDA, INC.   |  MOLECULAR TEMPLATES, INC.   |  POSEIDA THERAPEUTICS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SWIFT HOLDCO LTD   |  WKCGRG HOLDINGS, INC.
TRISHA 
 
MILLICAN 
DIRECTOR
METACRINE, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  RECODE THERAPEUTICS, INC.
VOLKER 
 
SCHELLENBERGER 
EXECUTIVE OFFICER
VERSARTIS, INC.   |  AMUNIX PHARMACEUTICALS, INC.
OTELLO 
 
STAMPACCHIA 
DIRECTOR
OMEGA FUND III, L.P.   |  OMEGA FUND II, L.P.   |  TREVI THERAPEUTICS, INC.   |  MORPHIC HOLDING, LLC   |  ESSA PHARMA INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SCORPION THERAPEUTICS, INC.   |  IKENA ONCOLOGY, INC.   |  OMEGA FUND VIII, L.P.   |  THIRD ARC BIO, INC.
JAMES 
 
TOPPER 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  INCLINE THERAPEUTICS, INC.   |  PORTOLA PHARMACEUTICALS INC   |  ATTEROCOR, INC.   |  SEMNUR PHARMACEUTICALS, INC.   |  PRONAI THERAPEUTICS INC   |  ALLENA PHARMACEUTICALS, INC.   |  CHANRX CORP.   |  ANAPTYSBIO INC   |  LAGUNA PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  MERGANSER BIOTECH, INC.   |  ALCRESTA, INC.   |  ALCRESTA THERAPEUTICS, INC.   |  MILLENDO THERAPEUTICS, INC.   |  APTINYX INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  ENLAZA THERAPEUTICS, INC.
ANGIE 
 
YOU 
EXECUTIVE OFFICER, DIRECTOR
ARAGON PHARMACEUTICALS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  RAYZEBIO, INC.   |  ORIC PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-26 
2021-01-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2021-01-07 
2020-07-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-06-17 
2020-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#